FN1 and cancer: These adipocyte-derived MSCs respond to Wnt3a secretion by tumor cells by reactivating Wnt/β-catenin, increasing expression of the marker FSP1, but not αSMA, increasing fibronectin and collagen I secretion, and enhancing cancer cells’ migratory and invasive capabilities [192].